Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 3.30
Ask: 4.80
Change: 0.19 (4.92%)
Spread: 1.50 (45.455%)
Open: 3.86
High: 0.00
Low: 0.00
Prev. Close: 3.86
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: Doubts about further Chinese stimulus

Mon, 20th Aug 2012 07:43

City sources predict the FTSE 100 will open up five points from Friday's close of 5,852, having gained 18 points during Friday's session following positive data from the US. Over the weekend it was reported in Europe by the Handelsblatt newspaper that the European Union could appoint the European Central Bank (ECB) as the supervisor of Europe's banking sector. Investors also took note of remarks out of Spain´s Economics Minister asking the ECB to commit to unlimited sovereign bond buying. Of interest as well, Chinese stocks fell to the lowest level since March 2009 last night after real-estate prices rose in the largest number of cities in 14 months in July, creating concerns that economic authorities may hold off on further monetary stimulus. Back in the UK, average asking prices for homes in England and Wales fell 2.4% month-on-month in August according to property website Rightmove. Values fell by 1.2% in London.In a separate report, the British Retail Consortium said visits to UK stores declined at a 2.3% year-on-year pace in the three months through July. House-builder Bovis Homes saw profits come in ahead of forecasts in the first half, helping the firm to double its interim dividend. Pre-tax profits themselves actually doubled in the six months to June 30th, up 100% from £8.1m to £16.2m. Peel Hunt was expecting a figure closer to £14.6m. Revenues gained 27% from £133.6m to £170.3m, as legal completions improved 18% from 801 homes to 944 homes with an average sales price of £164,400, up from £163,400 in the same period the year before. The dividend per share for the first half was hiked from 1.5p to 3.0p.Nanoco, the AIM-listed manufacturer of cadmium-free quantum dots and other nanomaterials, has won three grants from the UK government worth almost three-quarters of a million pounds. The grants, which total £736,000 together, were awarded by the UK's innovation agency, the Technology Strategy Board (TSB), which looks to boost the economy by stimulating and supporting business-led innovation, Nanoco said on Monday morning. Biotech group Proteome Sciences has agreed to work with CHDI Foundation Inc on a systems biology project regarding Huntington's disease. Initially, Proteome will provide its PS Biomarker Services protein profiling to CHDI's research programmes. The analyses will be performed at Proteome's facility in Frankfurt, Germany.
More News
2 Apr 2019 11:20

Proteome Sciences Annual Loss Narrows But Misses Expectations

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday reported a narrowed annual loss, lagging behind the company's expectations.Proteome Sciences shares were trading down 18% at a

Read more
23 Jan 2019 11:14

Proteome Sciences Expects Narrowed Annual Loss On Lower Expenses

LONDON (Alliance News) - Proteome Sciences PLC on Wednesday said it expects to post a narrowed loss for 2018 due to an ongoing cost savings programme and despite revenue taking a hit from weak in

Read more
23 Nov 2018 13:50

DIRECTOR DEALINGS: Proteome Sciences Non-Exec Director Buys Shares

LONDON (Alliance News) - Proteome Sciences PLC on Friday said Non-Executive Director Martin Diggle purchased shares in the biomarker research company following a transaction on acquired 500,000 at

Read more
6 Nov 2018 10:43

WINNERS & LOSERS SUMMARY: IWG Rises After Strong Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Associated up

Read more
6 Nov 2018 09:46

Proteome Sciences Shares Hit As It Expects Operating Loss Like In 2017

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday it expects an operating loss "similar to 2017" in 2018, as the firm's overall performance remains behind shares were down

Read more
12 Sep 2018 17:37

DIRECTOR DEALINGS: Proteome Non-Executive Director Buys Shares

LONDON (Alliance News) - Drug development company Proteome Sciences PLC said Non-Executive Director Martin Diggle purchased 601,582 shares at a price of 3.60 pence per share on this GBP21,657 now

Read more
7 Sep 2018 16:40

DIRECTOR DEALINGS: Proteome Sciences Non-Exec Director Buys Shares

LONDON (Alliance News) - Biopharmaceutical research firm Proteome Sciences PLC said Friday Non-Executive Director Martin Diggle purchased 469,866 shares at a price of 3.60 pence each on acquired a

Read more
14 Aug 2018 17:58

DIRECTOR DEALINGS: Proteome Sciences non-Exec Director Acquires Shares

LONDON (Alliance News) - Proteome Sciences PLC on Tuesday said Non-Executive Director Martin Diggle purchased shares in the science research company.In a transaction on Monday, Diggle at a

Read more
9 Aug 2018 14:50

DIRECTOR DEALINGS: Fund Linked To Proteome Director Buys Shares

LONDON (Alliance News) - Proteome Sciences said Thursday that Vulpes Life Sciences Fund purchased 1.4 million shares in the company on Tuesday at 3.50 pence each.Vulpes now has a 19.6% in a

Read more
2 Aug 2018 18:15

DIRECTOR DEALINGS: Proteome Non-Exec Director's Fund Buys Shares

LONDON (Alliance News) - Proteome Science PLC said Thursday that Vulpes Life Sciences Fund, a firm related to a non-executive director Martin Diggle, has bought shares in the company.Diggle

Read more
31 Jul 2018 17:45

DIRECTOR DEALINGS: Fund Linked To Proteome Non-Exec Buys Shares

LONDON (Alliance News) - Proteome Sciences PLC said on Tuesday Vulpes Life Sciences Fund bought shares in the company on Friday.Proteome Non-Executive Martin Diggle is also a director of at

Read more
27 Jul 2018 12:52

Vulpes Buys Proteome Sciences Shares, Raising Joint Director Interest (ALLISS)

LONDON (Alliance News) - Pharmeceutical company Proteome Sciences PLC said Friday that Vulpes Life Sciences Fund purchased 171,000 shares at a price of 2.85 pence per share on in Proteome were up

Read more
24 Jul 2018 10:45

Proteome Shares Drop On Half-Year Performance Behind Expectations

LONDON (Alliance News) - Shares in Proteome Sciences PLC tumbled on Tuesday as the company reported half-year performance "behind expectations".Shares were trading down 11% at for

Read more
24 Jul 2018 08:04

Proteome punished as sales fail to perk up

(Sharecast News) - Proteome Sciences trimmed losses in the first half as the protein biomarker specialist cut costs and revenues stalled.

Read more
30 May 2018 14:58

Proteome Sciences Meeting Expectations Despite Slow First Quarter

LONDON (Alliance News) - Proteome Sciences PLC Chief Executive Officer Jeremy Haigh said Wednesday at the company's annual general meeting trading in the year-to-date has been in line despite

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.